AI Summary & Key Takeaways
AI InsightThese findings disclose the need for the rational use of medicine dissemination interventions for all physicians focusing on more effective use of P-drug list.
📌 3 Key Takeaways
Abstract
OBJECTIVE: Physicians’ personal (P) drugs, which were ranked by priority, may show variations even for the same indication. We aimed to evaluate physicians’ knowledge and attitudes regarding P-drug list preparation with respect to the rationaluse of medicine context.METHODS: A total of 1062 family physicians (FPs) and 562 specialist physicians (SPs) were interviewed and questionedabout their knowledge and attitude regarding P-drug list preparation.RESULTS: Compared with SPs (64.9%), significantly more number of FPs (72.8%) prepared a P-drug list. Women were morelikely to prepare the P-drug list in both groups; gender comparison showed that significantly more number of female FPs(75.9%) exhibited this attitude than female SPs (67.8%) (p=0.002). Among SPs, the trend for P-drug list preparation attitudedecreased with increasing age (p=0.006), and significantly less number of senior physicians showed this attitude comparedwith junior physicians (p=0.007). The most common source of information referred to by FPs (78.9%) and SPs (74.3%) during P-drug list preparation was “pharmaceutical company activities.” More than 80% of responders (80.9% of FPs and 83.6%of SPs) specified that a difference “exists” or “partially exists” between original and generic drugs. Approximately one in 10physicians in both groups stated that they “rarely/never” consider their patients’ “liver/kidney disease” during prescribing.CONCLUSION: More prominently in male and senior physicians, the attitude of P-drug list preparation remained lower thanexpected. Moreover, it is remarkable that pharmaceutical company promotions are the most common source of informationfor drug selection. These findings disclose the need for the rational use of medicine dissemination interventions for all physicians focusing on more effective use of P-drug list.